Novartis tests new injection to heal damaged achilles tendons
NCT ID NCT05592990
Summary
This study tested whether a single injection of experimental particles called NGI226 could help heal painful Achilles tendons. Researchers compared the injection to a placebo in 45 people with chronic tendon pain that hadn't improved with standard treatments. The main goals were to check safety and see if the treatment could restore the tendon's strength and flexibility.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACHILLES TENDINOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Research LLC
Deerfield Beach, Florida, 33064, United States
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
-
Novartis Investigative Site
Caluire-et-Cuire, 69300, France
-
Novartis Investigative Site
Berlin, 10117, Germany
-
Novartis Investigative Site
Hamburg, 20149, Germany
-
Novartis Investigative Site
Hamburg, 22415, Germany
-
Tucson Orthopedic Institute PC
Tucson, Arizona, 85712, United States
Conditions
Explore the condition pages connected to this study.